Komboglyze
saxagliptin, metformin hydrochloride
saxagliptin/metformin hydrochloride
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor, pharmacist or nurse.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
What Komboglyze is and what it is used for
What you need to know before you take Komboglyze
How to take Komboglyze
Possible side effects
How to store Komboglyze
Contents of the pack and other information
This medicine contains two different substances called:
saxagliptin, part of a class of medicines called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors), and metformin, part of a class of medicines called biguanides.
Both belong to a group of medicines called oral anti-diabetics.
This medicine is used to treat a type of diabetes called ‘type 2 diabetes’.
Saxagliptin and metformin work together to control your blood sugar. They increase the levels of insulin after a meal. They also lower the amount of sugar made by your body. Along with diet and exercise, this helps lower your blood sugar. This medicine can be used alone or together with other antidiabetic medicines, including insulin.
To control your diabetes, you still need to diet and exercise, even when you are taking this medicine. So it is important to keep following the advice about diet and exercise from your doctor or nurse.
If you are allergic to saxagliptin, metformin or any of the other ingredients of this medicine (listed in section 6);
If you have had a serious allergic (hypersensitive) reaction to any other similar medications that you take to control your blood sugar.
Symptoms of a serious allergic reaction may include:
Rash
Raised red patches on your skin (hives)
Swelling of the face, lips, tongue, and throat that may cause difficulty in breathing or swallowing.
If you have these symptoms, stop taking this medicine and call your doctor or nurse right away.
If you have ever had a diabetic coma;
If you have uncontrolled diabetes, with, for example, severe hyperglycaemia (high blood glucose), nausea, vomiting, diarrhoea, rapid weight loss, lactic acidosis (see “Risk of lactic acidosis” below) or ketoacidosis. Ketoacidosis is a condition in which substances called ‘ketone bodies’ accumulate in the blood and which can lead to a diabetic pre-coma. Symptoms include stomach pain, fast and deep breathing, sleepiness or your breath developing an unusual fruity smell;
If you have severely reduced kidney function or problems with your liver;
If you have recently had a heart attack or if you have heart failure or serious problems with your blood circulation or difficulties in breathing which could be a sign of heart problems;
If you have a severe infection or are dehydrated (have lost a lot of water from your body);
If you are breast-feeding (see also “Pregnancy and breast-feeding”);
If you drink a large amount of alcohol (either every day or only from time to time) (please see section “Komboglyze with alcohol”);
Do not take this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking this medicine.
Warnings and precautions: Risk of lactic acidosis
Komboglyze may cause a very rare, but very serious side effect called lactic acidosis, particularly if your kidneys are not working properly. The risk of developing lactic acidosis is also increased with uncontrolled diabetes, serious infections, prolonged fasting or alcohol intake, dehydration (see further information below), liver problems and any medical conditions in which a part of the body has a reduced supply of oxygen (such as acute severe heart disease).
If any of the above apply to you, talk to your doctor for further instructions.
Symptoms of lactic acidosis include:
vomiting
stomach ache (abdominal pain)
muscle cramps
a general feeling of not being well with severe tiredness
difficulty in breathing
reduced body temperature and heartbeat
Lactic acidosis is a medical emergency and must be treated in a hospital.
Talk to your doctor or pharmacist before taking Komboglyze
If you have type 1 diabetes (your body does not produce any insulin). This medicine should not be used to treat this condition;
If you have or have had a disease of the pancreas;
If you are taking insulin or an antidiabetic medicine known as ‘sulphonylurea’, your doctor may want to reduce your dose of insulin or the sulphonylurea when you take either of them together with this medicine, in order to avoid low blood sugar;
If you have had allergic reactions to any other medicines that you take to control the amount of sugar in your blood;
If you have a problem or take a medicine that can lower your body’s defence against infections;
If you have ever had heart failure or you have other risk factors for developing heart failure such as problems with your kidneys. Your doctor will advise you of the signs and symptoms of heart failure. You should call your doctor, pharmacist or nurse immediately if you experience any of these symptoms. Symptoms can include, but are not limited to, increasing shortness of breath, rapid increase in weight and swelling of the feet (pedal oedema);
If you need to have major surgery, you must stop taking Komboglyze during and for some time after the procedure. Your doctor will decide when you must stop and when to restart your treatment with Komboglyze.
Diabetic skin lesions are a common complication of diabetes. Rash has been seen with saxagliptin and with certain anti-diabetic medicines in the same class as saxagliptin. Follow the recommendations for skin and foot care that your doctor or nurse gave you. Contact your doctor if you encounter blistering of the skin, as it may be a sign for a condition called bullous pemphigoid. Your doctor may ask you to stop Komboglyze.
If any of the above apply to you, or if you are not sure, talk to your doctor or pharmacist before taking this medicine.
During treatment with this medicine, your doctor will check your kidney function at least once a year or more frequently if you are elderly and/or if you have worsening kidney function.
Komboglyze is not recommended for use in children and adolescents under 18 years. It is not known if this medicine is safe and effective when used in children and adolescents under 18 years of age.
If you need to have an injection of contrast medium that contains iodine into your bloodstream, for example in the context of an X-ray or scan, you must stop taking Komboglyze before or at the time of the injection. Your doctor will decide when you can restart your treatment with Komboglyze.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. You may need more frequent blood glucose and kidney function tests, or your doctor may adjust the dosage of Komboglyze. It is especially important to mention the following:
cimetidine, a medicine used to treat stomach problems
ketoconazole which is used to treat fungal infections
bronchodilators (beta-2 agonists) which are used to treat asthma
diltiazem which is used for high blood pressure
rifampicin, an antibiotic used to treat infections such as tuberculosis
corticosteroids, which are used to treat inflammation in diseases like asthma and arthritis
carbamazepine, phenobarbital or phenytoin, which are used to control fits (seizures) or long-term pain
medicines which increase urine production (diuretics)
medicines used to treat pain and inflammation (NSAID and COX-2-inhibitors, such as ibuprofen and celecoxib)
certain medicines for the treatment of high blood pressure (ACE inhibitors and angiotensin II
receptor antagonists).
If any of the above apply to you, or if you are not sure, talk to your doctor or pharmacist before taking this medicine.
Avoid excessive alcohol intake while taking Komboglyze since this may increase the risk of lactic acidosis (see “Warnings and precautions”).
Do not take this medicine if you are pregnant or might become pregnant. This is because it may affect the baby.
Do not take this medicine if you are breast-feeding or plan to breast-feed. This is because metformin passes into human milk in small amounts.
Ask your doctor or pharmacist for advice before taking any medicine.
Saxagliptin and metformin have a negligible influence on the ability to drive and use machines. Hypoglycaemia may affect your ability to drive and use machines or work with safe foothold and there is a risk of hypoglycaemia when taking this medicine in combination with medicines known to cause hypoglycaemia such as insulin and sulphonylureas.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
If your doctor prescribes this medicine together with a sulphonylurea or insulin, remember to take this other medicine as directed by your doctor to achieve the best results for your health.
The amount of this medicine that you will take varies depending on your condition and the doses you currently take of metformin and/or individual tablets of saxagliptin and metformin. Your doctor will tell you exactly the dose of this medicine to take.
The recommended dosing is one tablet twice a day.
If you have reduced kidney function, your doctor may prescribe a lower dose.
Take this medicine by mouth.
Take with a meal to lower your chance of getting an upset stomach.
To control your diabetes, you still need to diet and exercise, even when you are taking this medicine. So it is important to keep following the advice about diet and exercise from your doctor or nurse. In particular, if you are following a diabetic weight control diet, keep on with this while you are taking this medicine.
If you take more Komboglyze tablets than you should, talk to a doctor or go to a hospital straight away. Take the medicine pack with you.
If you forget to take a dose of this medicine, take it as soon as you remember. However, if it is time for your next dose, skip the missed dose and take your next dose at the usual time.
Do not take a double dose of this medicine to make up for a forgotten dose.
Keep taking this medicine until your doctor tells you to stop. This is to help keep your blood sugar under control.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You should call your doctor if you experience the following side effects:
severe joint pain.
Common (may affect up to 1 in 10 people)
headache
muscle pain (myalgia)
being sick or indigestion (dyspepsia)
infection of the structures that carry urine (urinary tract infection)
infection of the upper airways
inflamed nose or throat such as with a cold or sore throat
inflamed stomach (gastritis) or gut, sometimes caused by an infection (gastroenteritis)
infection of your sinuses, sometimes with a feeling of pain and fullness behind your cheeks and eyes (sinusitis)
flatulence
dizziness
tiredness (fatigue).
Uncommon (may affect up to 1 in 100 people)
joint pain (arthralgia)
difficulties in getting or maintaining an erection (erectile dysfunction).
Common
dizziness
tiredness (fatigue).
Not known (frequency cannot be estimated from the available data):
constipation
blistering of the skin (bullous pemphigoid)
Some patients have had a small reduction in the number of one type of white blood cells (lymphocytes) shown in a blood test when saxagliptin was used alone or in combination. In addition, some patients have reported rash and skin reactions (hypersensitivity) while taking saxagliptin.
During post-approval use of saxagliptin, additional side effects have been reported that include serious allergic reactions (anaphylaxis), and swelling of the face, lips, tongue, and throat that may cause difficulty in breathing or swallowing. If you have an allergic reaction, stop taking this medicine and call your doctor right away. Your doctor may prescribe a medicine to treat your allergic reaction and a different medicine for your diabetes.
Very common (may affect more than 1 in 10 people)
nausea, vomiting
diarrhoea or stomach pain
loss of appetite.
Common
a metallic taste in your mouth.
Very rare
decreased vitamin B12 levels
liver problems (hepatitis)
redness of the skin (rash) or itching.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and the carton after EXP. The expiry date refers to the last day of that month.
Store below 25°C.
Do not use this medicine if the package is damaged or shows signs of tampering.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substances are saxagliptin and metformin hydrochloride. Each film-coated tablet contains
2.5 mg saxagliptin (as hydrochloride) and 850 mg metformin hydrochloride.
The other ingredients (excipients) are:
Tablet core: povidone K30, magnesium stearate.
Film-coating: polyvinyl alcohol, macrogol 3350, titanium dioxide (E171), talc (E553b), iron oxide red (E172), iron oxide yellow (E172).
Printing ink: shellac, indigo carmine aluminium lake (E132).
Komboglyze 2.5 mg/850 mg film-coated tablets (‘tablets’) are light brown to brown and round, with “2.5/850” printed on one side and “4246” printed on the other side, in blue ink.
Komboglyze is available in aluminium foil blister. The pack sizes are 14, 28, 56 and 60
film-coated tablets in non-perforated blisters, multipacks containing 112 (2 packs of 56) and 196 (7 packs of 28) film-coated tablets in non-perforated blisters and 60 x1 film-coated tablets in perforated unit dose blisters.
Not all pack sizes may be marketed in your country.
AstraZeneca AB
SE-151 85 Södertälje Sweden
AstraZeneca AB Gärtunavägen
SE-151 85 Södertälje Sweden
AstraZeneca UK Limited Silk Road Business Park Macclesfield
Cheshire SK10 2NA
United Kingdom
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
UAB AstraZeneca Lietuva Tel: +370 5 2660550
АстраЗенека България ЕООД Тел.: +359 (2) 44 55 000
AstraZeneca Czech Republic s.r.o. Tel: +420 222 807 111
Associated Drug Co. Ltd Tel: +356 2277 8000
AstraZeneca BV
Tel: +31 79 363 2222
AstraZeneca
Tel: +372 6549 600
AstraZeneca AS
Tlf: +47 21 00 64 00
AstraZeneca A.E.
Τηλ: +30 2 106871500
AstraZeneca Österreich GmbH Tel: +43 1 711 31 0
AstraZeneca Farmacéutica Spain, S.A. Tel: +34 91 301 91 00
AstraZeneca Pharma Poland Sp. z o.o. Tel.: +48 22 245 73 00
AstraZeneca
Tél: +33 1 41 29 40 00
AstraZeneca Produtos Farmacêuticos, Lda. Tel: +351 21 434 61 00
AstraZeneca Pharma SRL Tel: +40 21 317 60 41
AstraZeneca Pharmaceuticals (Ireland) DAC Tel: +353 1609 7100
AstraZeneca UK Limited Tel: +386 1 51 35 600
Vistor hf.
Sími: +354 535 7000
AstraZeneca S.p.A. Tel: +39 02 9801 1
AstraZeneca Oy
Puh/Tel: +358 10 23 010
Αλέκτωρ Φαρµακευτική Λτδ Τηλ: +357 22490305
AstraZeneca AB
Tel: +46 8 553 26 000
SIA AstraZeneca Latvija Tel: +371 67377100
AstraZeneca UK Ltd Tel: +44 1582 836 836